Anastrozole Tablet, Coated
Product Images NDC 68382-209

8 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 68382-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 01)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 01)
Chemical structure of Anastrozole, illustrating the arrangement of its atoms and bonds typical for this active ingredient.*
FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 02)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 02)
A Kaplan-Meier survival curve chart showing proportion alive and disease-free over time in months, comparing randomized treatment with anastrozole and tamoxifen. The chart includes a legend and displays the number of patients at risk at various time points for each treatment group.*
FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 03)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 03)
A line graph comparing disease-free survival over time in months between treatments with anastrozole and tamoxifen. The y-axis shows the proportion of patients alive and disease-free, starting near 1.0 and declining slightly over 90 months. The x-axis tracks disease-free survival time in months. Two lines represent randomized treatment groups: a dashed line for anastrozole and a solid line for tamoxifen, with patient numbers at risk listed below the graph for both groups at specified time points.*
FDA Label Image

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 04)

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 04)
A Kaplan-Meier curve displaying the proportion of patients event-free over time in months, comparing Anastrozole and Tamoxifen treatments. The graph plots event-free survival on the vertical axis and time to event in months on the horizontal axis, with numbers of patients at risk shown at intervals up to 120 months. The vertical axis has been truncated for clarity.*
FDA Label Image

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 05)

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 05)
Kaplan-Meier survival curve chart depicting proportion event-free over time in months, comparing randomized treatment groups: Anastrozole and Tamoxifen. The vertical axis shows proportion event-free ranging approximately from 0.50 to 1.00, while the horizontal axis shows time to event up to 120 months. Below the chart, a table lists the number of patients at risk at specified month intervals for each treatment group.*
FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 06)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 06)
A Kaplan-Meier survival curve chart showing the proportion of patients not progressing over time (months) comparing two randomized treatments: Anastrozole and Tamoxifen. The y-axis represents the proportion not progressing, and the x-axis shows time to progression in months. Patient numbers at risk at various time points are listed below the x-axis.*
FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 07)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 07)
A line graph showing time to progression (months) on the x-axis and proportion not progressing on the y-axis for two randomized treatments: Anastrozole and Tamoxifen. The graph compares progression over approximately 40 months and includes a table indicating the number of patients at risk at various time points.*
FDA Label Image

Anastrozole Tablets, 1mg (577b7171 5da0 4291 Af07 5e4653ffb3aa 08)

Anastrozole Tablets, 1mg (577b7171 5da0 4291 Af07 5e4653ffb3aa 08)
Label for Anastrozole Tablets, USP 1 mg oral coated tablets by Zydus Pharmaceuticals USA Inc. The label states the product contains 1,000 tablets and is prescription only (Rx only). It contains dosage instructions, storage information, and manufacturer details, indicating Zydus Lifesciences Ltd. in India and distribution by Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.